Nyxoah S.A., a Belgian medical technology firm, specializes in creating and marketing innovative solutions for sleep-related breathing disorders. Its flagship product, the Genio system, is approved by the European Union and provides unique hypoglossal neurostimulation therapy to combat moderate to severe obstructive sleep apnea. Since its inception in 2009, the company has been based in Mont-Saint-Guibert, Belgium.